Chemical and Engineering News has named Fund investment, Lodo Therapeutics, one of its top 10 startups to watch.
Lodo Therapeutics takes an innovative approach to natural products drug discovery, using bacteria found in soil to uncover gene sequences that hold promising molecules to combat disease and infection. The Wall Street Journal recently wrote on the company’s use of New York City soil as a source of bacteria for their research, finding it to be as rich in microbes as soil found in the Amazon rain forest.
The Fund first invested in Lodo Therapeutics in 2015 as part of its life sciences portfolio, the company has also received funding from the Bill and Melinda Gates Foundation.
Institutional Investor has published Fintech’s Most Powerful Dealmakers of 2016, naming Partnership Fund President & CEO Maria Gotsch as number 12 on the list.
The list highlights the crucial role that funders and dealmakers play in Fintech, focusing on the collaborative aspect of the industry.
See the full profile here.
Kathryn Wylde, President and CEO at the Partnership for New York City, and Winston Fisher, a Partner at Fisher Brothers, appeared on WCNY’s Capitol Pressroom this morning to discuss their proposals for economic development in the city through the Regional Economic Development Council (REDC). They spoke about investments the REDC has made over the years through workforce development projects and community revitalization initiatives and the impact these have on areas in need of support.
Listen to the radio segment here:
At this week’s Money 20/20 conference, Mastercard announced a partnership with Kasisto to create a Mastercard bot for banks.
Kasisto is a graduate of the 2014 FinTech Innovation Lab and a Partnership Fund portfolio company.
The bot, Mastercard Kai, will use Kasisto’s Kai Banking on Messaging technology allowing customers a human-like conversation with their bank.
Learn more about the bot, currently in pilot phase, on the Kasisto website.
Program helps leading financial technology entrepreneurs accelerate product and business development, and solidifies New York City’s position as the nation’s fintech capital
Applications are now being accepted for New York’s seventh annual FinTech Innovation Lab, a 12-week program co-founded by Accenture (NYSE: ACN) and the Partnership Fund for New York City that helps early- and growth-stage financial technology (fintech) companies accelerate product and business development by gaining exposure to top bank and venture capital executives. Applications are available at www.fintechinnovationlab.com and are due by December 1, 2016. An information session will be held for applicants on November 7. Read More →
Annual Program Selects 23 Senior Executives Committed to Corporate Civic Engagement
NEW YORK, NY, October 14, 2016 – The Partnership for New York City, the city’s leading business organization, today announced the newest class of David Rockefeller Fellows, a group of twenty-three senior executives selected to participate in a year-long business and civic leadership program.
The 2016-2017 class of Fellows represents a cross-section of industries, including financial services, law, technology, retail and media. During the year, Fellows will have the opportunity to learn firsthand how New York City is run from top leaders in the private, public, and nonprofit sectors. Since its inception in 1989, 362 individuals have participated in the program. Read More →
“Governor Cuomo is accelerating our major transportation projects and leveraging public partnerships to ensure that these projects are of the highest quality and that they’re delivered on time. Today’s announcement is great news for all New Yorkers, especially for the employers and commuters who will directly benefit from the new Penn-Farley Complex.”
Nina Tandon, CEO of EpiBone appeared on CNBC last week, discussing the company’s technology allowing patients to grow new bones in a lab to help heal from injury, illness or surgery.
The Partnership Fund invested in EpiBone through our BioAccelerate funding program—which provides early stage funding to NYC-based biotech companies spun out of local academic institutions. Located in Brooklyn, at the SUNY Downstate incubator and spun out of Columbia University, EpiBone is engineering stem cells into anatomically precise and patient-specific implants for skeletal reconstruction.
On Wednesday 21st September Michael Simas, Executive Vice President of the Partnership for New York City, testified to the New York City Council Committee on Education on Career and Technical Education (CTE) Programs. Below is a summary of his comments to the committee and the recording of the full session can be found here (Partnership comments start at 1:27).
Kathryn Wylde, President and CEO of the Partnership for New York City, has been inducted into Crain’s 2016 Hall of Fame, an award bestowed on business leaders who have positively impacted the city through their work and civic and philanthropic activities.
Wylde has been honored alongside an esteemed group of business leaders including Ken Langone, Invemed Associates; Geoffrey Canada, Harlem’s Children Zone; Stephen Berger, Odyssey Investment Partners; and Bruce Ratner, Forest City Ratner Cos.
The inductees were featured in this week’s Crain’s New York Business, and discussed their careers, successes and legacies.
Commenting on her success Wylde said, “I’ve always seen that as a unique opportunity—using my experience to build bridges with the leadership of the business community and the city government.”
The full article is available on Crain’s.